英文醫(yī)學(xué)投稿需注意的事項1.ppt

Chinese Medical Journal,英文醫(yī)學(xué)投稿需注意的事項,郝秀原 中華醫(yī)學(xué)會 中華醫(yī)學(xué)雜志英文版編輯部,Chinese Medical Journal,英文醫(yī)學(xué)投稿需注意的事項,正確選擇期刊 投稿前的準(zhǔn)備 投稿后若干事宜 國人投稿英文雜志易犯錯誤討論,Chinese Medical Journal,正確選刊SCI or SCI expanded Specialized or general medicine,綜合醫(yī)學(xué)和內(nèi)科學(xué) SCI：62種 SCI expanded:160種 心血管 SCI：48種 SCI expanded:110種,外周血管 SCI：36種 SCI expanded:68種,Chinese Medical Journal,正確選刊IF(心血管）,Chinese Medical Journal,正確選刊IF(心血管）,Chinese Medical Journal,正確選刊IF(心血管）,Chinese Medical Journal,正確選刊IF(心血管）,Chinese Medical Journal,正確選刊Scope,論文主題是否在刊物的征稿范圍內(nèi) 期刊的聲望 撰寫格式是否與刊物要求一致 About us 期刊的稿約 （Instructions to authors) 期刊的目錄（Table of Contents),Chinese Medical Journal,正確選刊其它,刊出率 審稿周期 刊出周期：某些期刊刊登文章的投稿和接收日期（submitted and accepted dates），作者可據(jù)此計算出論文出版時滯（發(fā)表周期） 版面費(fèi) 注意廣告數(shù)量，以間接判斷期刊質(zhì)量,Chinese Medical Journal,舉例 - Hypertension,Hypertension publishes scientific investigation of the highest quality in the broad field of blood pressure regulation and pathophysiology, clinical treatment, and prevention of hypertension. The editors encourage submission of original articles that deal with basic, clinical, and population studies of hypertension and related fields such as nephrology, endocrinology, neuroscience, vascular biology, physiology, pharmacology, cellular and molecular biology, and genetics.,AHA Lippincott Williams & Wilkins, IF：7.368(2008),Chinese Medical Journal,Editor-in-Chief: John E. Hall, PhD Managing Editor: Gerry McAlpin Email: Editorial Office Address: Hypertension Editorial Office Frequency: Monthly Pages per year: 2,800 Review Process: Peer-reviewed Impact Factor/Ranking: The journal ranks #1 among all hypertension journals and #3 among 54 journals in the Peripheral Vascular Disease category Impact Factor = 7.368 Cited Half Life = 6.5 years Manuscript Acceptance Rate: 19% Lead Times: Time from Submission to First Decision = 2.8 weeks Time from Acceptance to Online Publication = 4.2 weeks Time from Acceptance to Print Publication = 7.0 weeks Circulation: Over 15,800 Supplements: Yes Indexed in: BIOSIS, CABS, Chemical Abstracts, Current Contents, EMBASE, and MEDLINE,Chinese Medical Journal,舉例 J. Hypertension,The journal consistently attracts the most important and highly innovative papers from the current research; our commitment to rapid publication ensures that these are published in the fastest time possible. In addition to primary papers from world-renowned experts, the Journal contains authoritative reviews that summarize and evaluate the most significant recent developments. Also included are special reports, original short papers containing innovative and time-sensitive information.,International Society of Hypertension European Society of Hypertension,Chinese Medical Journal,Chinese Medical Journal,舉例 J. C. Hypertension,The Journal of Clinical Hypertension is a peer-reviewed, monthly publication that serves family practitioners, internists, and cardiologists by providing objective, up-to-date information and practical recommendations on the treatment of hypertension. As newer studies are completed, they are summarized and critiqued. Reviews of recent publications in other journals and original papers that focus on the clinical management of hypertension are featured. JCH is the official journal of the American Society of Hypertension, Inc.,Science Citation Index Expanded Monthly,Chinese Medical Journal,舉例 Circulation,Circulation publishes articles related to research in and the practice of cardiovascular diseases, including observational studies, clinical trials, epidemiology, health services and outcomes studies, and advances in applied (translational) and basic research. Circulation: Heart Failure will include articles related to research into the pathophysiology of as well as in the evaluation and management of heart failure, including observational studies, clinical trials, epidemiology, and advances in applied (translational) research. Circulation: Arrhythmia and Electrophysiology will include articles related to research in and the practice of clinical cardiac electrophysiology and the diagnosis and management of cardiac arrhythmias, including observational studies, clinical trials, epidemiology, and advances in applied (translational) research . Circulation: Cardiovascular Interventions will include articles related to research in and the practice of the broad field of interventional cardiology (coronary, structural, adult congenital and peripheral vascular). Observational studies, clinical trials, and advances in applied (translational) research will be considered. Circulation: Cardiovascular Quality and Outcomes will include high-quality applied clinical, epidemiological, and health care policy papers related to cardiovascular diseases. The mission of the journal ?like outcomes research itself ?is to improve clinical care and health care delivery. The audience for this journal includes researchers, clinicians, policymakers, administrators, health plan executives and government agency professionals. The journal抯 purpose is to be a catalyst for outstanding science, to disseminate science and information that will enhance cardiovascular health and health care, to strengthen and expand the community of people committed to improving clinical care and population health, to inspire people to engage in scholarly activities of consequence.,Chinese Medical Journal,Editor-in-Chief: Joseph Loscalzo, MD, PhD Managing Editor: Karen Barry Editorial Office Address: Circulation 560 Harrison Avenue Suite 502 Boston, MA 02118 Frequency: Weekly Audience: Cardiologists, cardiovascular surgeons, electrophysiologists, internists, nurses and others interested in cardiovascular medicine Pages per year: 7,087 Review Process: Peer-reviewed Manuscript Acceptance Rate: 11% Lead Times for Original Research Articles: Submission to 1st Decision: 28 days; Acceptance to Print Publication: 77 days Circulation: Over 23,900 Supplements: Yes Indexed in: BIOSIS, CAB Abstracts, Chemical Abstracts, Current Contents, EMBASE, and MEDLINE Impact Factor/Ranking: Impact factor is 14.595- Ranks #1 among journals in the Cardiac & Cardiovascular Systems category, #1 among journals in the Hematology category, and #1 among journals in the Peripheral Vascular Disease category.,Chinese Medical Journal,舉例 JACC,The official journal of the American College of Cardiology and the leader in its field, JACC publishes original peer-reviewed clinical and experimental reports on all aspects of cardiovascular disease. Topics covered include coronary artery and valve disease, congenital heart defects, vascular surgery, cardiomyopathy, drug treatment, new diagnostic techniques, findings from the laboratory, and large multicenter studies of new therapies. Symposia, clinical reviews and updates, editorial commentary, and letters are regular features. JACC also publishes abstracts of papers presented at the annual scientific sessions of the American College of Cardiology and the reports and recommendations of the Bethesda Conferences on current topics in cardiovascular disease.,SCI IF：11.438 Monthly,Chinese Medical Journal,舉例 TRANSLATIONAL RESEARCH,Translational Research delivers clinical investigation and research articles to physicians, academic clinician-scientists, and laboratory consultants. Interdisciplinary and cross-disciplinary in scope, it keeps readers up-to-date on significant biomedical research from all subspecialties of internal medicine. Translational Research is known and respected around the world. The Journal is recommended for initial purchase in two Brandon-Hill studies, Selected List of Books and Journals for the Small medical Library and Selected List of Books and Journals in Allied Heath Sciences,IF:1.984,Chinese Medical Journal,舉例 JAMA,JAMA, published continuously since 1883, is an international peer-reviewed general medical journal published 48 times per year. JAMA is the most widely circulated medical journal in the world. JAMA is published in multiple international editions and languages. JAMAs 2008 impact factor is 31.7 . JAMAs acceptance rate is approximately 9% of the nearly 6000 solicited and unsolicited manuscripts it receives annually; its average time from submission to publication is 95 days and average time from receipt to rejection is 8 days. The Editor-in-Chief of JAMA is Catherine DeAngelis, MD, MPH,Chinese Medical Journal,舉例 The Lancet,The journal was, and remains, independent, without affiliation to a medical or scientific organisation. More than 180 years later, The Lancet is an independent and authoritative voice in global medicine. We seek to publish high-quality clinical trials that will alter medical practice; our commitment to international health ensures that research and analysis from all regions of the world is widely covered. Critical appraisal of research and reviews is ensured by strong Comment and Correspondence sections; The Lancets opinion and personality is communicated by three editorials every week; fast dissemination of priority issues is delivered by online first publication through ; and the continued success of our monthly specialty titles ensures that The Lancet delivers in-depth knowledge in key medical disciplines Between our first online publication in 1996 and today, 1.8 million users have registered at .,Chinese Medical Journal,舉例 NEJM,a) ORIGINAL RESEARCH Original Articles are scientific reports of the results of original clinical research. The text is limited to 2700 words, with an abstract, a maximum of 5 tables and figures (total), and up to 40 references. Special Articles are scientific reports of original research in such areas as economic policy, ethics, law, and health care delivery. The text is limited to 2700 words, with an abstract, a maximum of 5 tables and figures (total), and up to 40 references. b) CLINICAL CASES Brief Reports usually describe one to three patients or a single family. The text is limited to 2000 words, a maximum of 3 tables and figures (total), and up to 25 references. They begin with a brief summary of no more than 100 words. Clinical Problem-Solving manuscripts consider the step-by-step process of clinical decision making. Information about a patient is presented to an expert clinician or clinicians in stages (indicated by boldface type in the manuscript) to simulate the way such information emerges in clinical practice. The clinician responds (in regular type) as new information is presented, sharing his or her reasoning with the reader. The text should not exceed 2500 words, and there should be no more than 20 references. The use of clinical illustrative materials, such as x-ray films, is encouraged. Case Records of the Massachusetts General Hospital are solicited by the Case Records editors. c) REVIEW ARTICLES Review articles are usually solicited by the editors, but we will consider unsolicited material. Please contact the editorial office before writing a review article for the Journal. All review articles undergo the same peer-review and editorial process as original research reports. They should be written for the general physician, not specialists. Consequently, they may include material that might be considered too introductory for specialists in the field being covered.,Chinese Medical Journal,舉例 Ann Intern Med,Established in 1927 by the American College of Physicians (ACP), Annals of Internal Medicine is the premier internal medicine journal. Annals of Internal Medicines mission is to promote excellence in the clinical practice of internal medicine, to help physicians be well-informed citizens of the medical community and society, and to publish information that helps to advance the health of people worldwide. To achieve this mission, the journal publishes a wide variety of original research, review articles, practice guidelines, and commentary relevant to clinical practice, health care delivery, public health, health care policy, medical education, ethics, and research methodology. In addition, the journal publishes personal narratives that convey the feeling and the art of medicine. Annals of Internal Medicine has a large readership that includes the over 129,000 members of the American College of Physicians and many more physicians and researchers worldwide who read the journal via institutional subscriptions. Our 2008 impact factor of 17.5 makes the Annals of Internal Medicine one of the most cited general medical journals in the world. Material published in Annals is subject to peer review and the journal greatly appreciates the efforts of the over 17,000 volunteers in our reviewer database who provide critical input into our peer review process. Acceptance rates for original research range from 6-8% in recent years. Annals of Internal Medicine publishes new issues twice a month on the first and third Tuesday of each month.,IF:17.457,Chinese Medical Journal,選刊實(shí)例討論,Mortality attributable to smoking in China. BACKGROUND: Smoking is a risk factor for many diseases and has been increasingly prevalent in economically developing regions of the world. We aimed to estimate the number of deaths attributable to smoking in China. METHODS: We conducted a large, prospective cohort study in a nationally representative sample of 169,871 Chinese adults who were 40 years of age or older. Investigators for the China National Hypertension Survey collected data on smoking and other risk factors at a baseline examination in 1991 using a standard protocol. Follow-up evaluation was conducted in 1999 and 2000, with a response rate of 93.4%. We used multivariable-adjusted relative risk, prevalence of smoking, mortality, and population size in each age group, stratified according to sex, to calculate the number of deaths attributable to smoking in 2005. RESULTS: CONCLUSIONS: Our study documents that smoking is a major risk factor for mortality in China. Continued strengthening of national programs and initiatives for smoking prevention and cessation is needed to reduce smoking-related deaths in China.,N Engl J Med. 2009 Jan 8;360(2):150-9.,Chinese Medical Journal,選刊實(shí)例討論,Biventricular Pacing in Patients with Bradycardia and Normal Ejection Fraction . BACKGROUND: Observational studies suggest that conventional right ventricular apical pacing may have a deleterious effect on left ventricular function. In this study, we examined whether biventricular pacing is superior to right ventricular apical pacing in preventing deterioration of left ventricular systolic function and cardiac remodeling in patients with bradycardia and a normal ejection fraction. METHODS: In this prospective, double-blind, multicenter study, we randomly assigned 177 patients in whom a biventricular pacemaker had been successfully implanted to receive biventricular pacing (89 patients) or right ventricular apical pacing (88 patients). The primary end points were the left ventricular ejection fraction and left ventricular end-systolic volume at 12 months. RESULTS: CONCLUSIONS: In patients with normal systolic function, conventional right ventricular apical pacing resulted in adverse left ventricular remodeling and in a reduction in the left ventricular ejection fraction; these effects were prevented by biventricular pacing. (Centre for Clinical Trials number, CUHK_CCT00037.),N Engl J Med. 2009 Nov 15. Epub ahead of print,Chinese Medical Journal,1: Chan CY, et al. Images in cardivascular medicine. Detection of large aneurysm of Vieussens arterial ring after abnormal shadow on chest radiography. Circulation. 2009 Oct 13;120(15):e134-6. 2: Ding L, et al. Increased expression of integrin-linked kinase attenuates left ventricular remodeling and improves cardiac function after myocardial infarction. Circulation. 2009 Sep1;120(9):764-73. 3: An X, et al. Response gene to complement 32, a novel hypoxia-regulated angiogenic inhibitor. Circulation. 2009 Aug 18;120(7):617-27. 5: Yu Z, et al. Associations of physical activity with inflammatory factors, adipocytokines, and metabolic syndrome in middle-aged and older chinese people. Circulation. 2009 Jun 16;119(23):2969-77. 8: Li Y, et al. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution. Circulation. 2009 Apr 21;119(15):2040-50. 9: Zhang J, et al. Collagen-targeting vascular endothelial growth factor improves cardiac performance after myocardial infarction. Circulation. 2009 Apr 7;119(13):1776-84. 12: Zhang X,et al. Elevated heat shock protein 60 levels are associated with higher risk of coronary heart disease in Chinese. Circulation. 2008 Dec 16;118(25):2687-93. 13: Wu Y, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation. 2008 Dec 16;118(25):2679-86. 14: Tan WQ, Wang JX, Lin ZQ, Li YR, Lin Y, Li PF. Novel cardiac apoptotic pathway: the dephosphorylation of apoptosis repressor with caspase recruitment domain by calcineurin. Circulation. 2008 Nov 25;118(22):2268-76. Epub 2008 Nov 10. PubMed PMID: 19001025. 15: He Y, Lam TH, Jiang B, Wang J, Sai X, Fan L, Li X, Qin Y, Hu FB. Passive smoking and risk of peripheral arterial disease and ischemic stroke in Chinese women who never smoked. Circulation. 2008 Oct 7;118(15):1535-40. Epub 2008 Sep 22. PubMed PMID: 18809795.,Circulation publishes articles related to research in and the practice of cardiovascular diseases, including observational studies, clinical trials, epidemiology, health services and outcomes studies, and advances in applied (translational) and basic research.,Chinese Medical Journal,Chinese Medical Journal,英文投稿需注意的事項,正確選擇期刊 投稿前的準(zhǔn)備 投稿后若干事宜 國人投稿英文雜志易犯錯誤討論,Chinese Medical Journal,投稿前的準(zhǔn)備,5C正確（correctness）、清楚（clarity）、簡潔（concision）、完整（completion）和一致性（consistency） 論文格式 投稿信和文題頁 語言規(guī)范 倫理學(xué)要求 文檔準(zhǔn)備 圖表 討論和結(jié)論 參考文獻(xiàn),Chinese Medical Journal,投稿前準(zhǔn)備之一論文